Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Quest Diagnostics (DGX) stock in plain English

Free brief · no signupStart here
DGXPublished Nov 16, 2026
Quest Diagnostics Inc
Healthcare · Diagnostics & Research
Performs clinical laboratory testing, routine blood screenings, and specialized diagnostic procedures for patients and healthcare providers.
Assets:
2,100 patient centersOperates collection sites across the United States
Advanced test menuIncludes specialized oncology assays and Alzheimer biomarkers
50,000 employeesStaffs laboratories, phlebotomy stations, and logistics routes
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

61
OPS ScoreOperating finances
Latest quote
-0.23%$259.09
$28.50B
25.8×
$11.83B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 16, 2026Quotes updated Nov 20, 04:10 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was DGX. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Quest Diagnostics (DGX) do?

Quest Diagnostics Inc (DGX) is a U.S.-listed company in Healthcare (Diagnostics & Research). What it does: Performs clinical laboratory testing, routine blood screenings, and specialized diagnostic procedures for patients and healthcare providers. Operates an expansive laboratory network serving one in three American adults across the country each year. It is worth $28.50B on the market and sold $11.83B over the last year.

Market cap
$28.50B
P/E ratio
25.8×
Annual sales
$11.83B
Sector
Healthcare
Industry
Diagnostics & Research
Brief updated
Nov 16, 2026

Brands and businesses behind DGX

  • Quest Health: Sells direct to consumer lab tests and screenings online without requiring an initial doctor visit.
  • Haystack Oncology: Provides minimal residual disease testing to detect lingering cancer cells using personalized liquid biopsy technology.
  • AD-Detect: Offers blood tests that measure amyloid proteins to help assess personal risk for Alzheimer disease.

DGX’s flags, in plain English

Each flag is a number from Quest Diagnostics’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 16, 2026.

Stupid Cash

Can pay this year's bills 1.7 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.

Earns Its Keep

Earns 15.1% a year on shareholders' money. The company earns a healthy return on the money its shareholders have put in.

Growth Cooling

Sales growth slowed to 3.2% a year over 5 years. Sales are growing more slowly than before, which makes the current share price harder to justify.

Questions about DGX

How big is Quest Diagnostics?

Quest Diagnostics’ market cap is $28.50B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $11.83B: what customers paid the company over the last year, before any costs.

What is DGX’s P/E ratio?

DGX’s P/E ratio is 25.8×. Investors pay about 25.8 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with DGX?

Pending Medicare fee reductions threaten payment rates across high-volume routine diagnostic tests. That is one risk on Quest Diagnostics’ card. Its first risk flag is Growth Cooling, explained above. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Quest Diagnostics’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. DGX’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card